Chargement en cours...
Antibody drug-conjugates targeting the tumor vasculature: Current and future developments
Reducing the blood supply of tumors is one modality to combat cancer. Monoclonal antibodies are now established as a key therapeutic approach for a range of diseases. Owing to the ability of antibodies to selectively target endothelial cells within the tumor vasculature, vascular targeting programs...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Landes Bioscience
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2726597/ https://ncbi.nlm.nih.gov/pubmed/20069754 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|